|
ARHGEF7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.28900043153635E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.74409999670533E-08 |
| Normal-vs-Stage2 |
6.29129999999423E-05 |
| Normal-vs-Stage3 |
3.97659682960239E-11 |
| Normal-vs-Stage4 |
6.12970000000157E-05 |
| Stage1-vs-Stage2 |
9.793000E-01 |
| Stage1-vs-Stage3 |
7.738300E-03 |
| Stage1-vs-Stage4 |
5.266400E-01 |
| Stage2-vs-Stage3 |
5.611900E-02 |
| Stage2-vs-Stage4 |
6.234200E-01 |
| Stage3-vs-Stage4 |
2.703200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47989961899009E-10 |
| Normal-vs-AfricanAmerican |
1.556120E-03 |
| Normal-vs-Asian |
8.399800E-03 |
| Caucasian-vs-AfricanAmerican |
4.203400E-01 |
| Caucasian-vs-Asian |
4.203900E-02 |
| AfricanAmerican-vs-Asian |
5.494000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82530000003567E-06 |
| Normal-vs-Female |
1.84210002807106E-09 |
| Male-vs-Female |
3.076600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.2561000000133E-06 |
| Normal-vs-Age(41-60Yrs) |
1.30050004099047E-09 |
| Normal-vs-Age(61-80Yrs) |
1.67180003174394E-09 |
| Normal-vs-Age(81-100Yrs) |
3.56449999999731E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.080650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.531500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.984200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.038400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.509600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.563000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.782650E-04 |
| Classical-VS-Follicular |
4.957000E-01 |
| Classical-VS-Other |
9.680000E-01 |
| Classical-VS-Normal |
5.0151999997361E-07 |
| Tall-VS-Follicular |
2.028400E-04 |
| Tall-VS-Other |
7.141600E-02 |
| Tall-VS-Normal |
4.94340124390646E-11 |
| Follicular-VS-Other |
8.557800E-01 |
| Follicular-VS-Normal |
1.037250E-04 |
| Other-VS-Normal |
2.996000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18889997846594E-09 |
| Normal-vs-N1 |
2.762700E-04 |
| N0-vs-N1 |
7.647200E-01 |
|
|
